219 related articles for article (PubMed ID: 9974407)
1. Study of the prothrombin gene 20201 GA variant in FV:Q506 carriers in relationship to the presence or absence of juvenile venous thromboembolism.
Ehrenforth S; von Depka Prondsinski M; Aygören-Pürsün E; Nowak-Göttl U; Scharrer I; Ganser A
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):276-80. PubMed ID: 9974407
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes.
Alhenc-Gelas M; Arnaud E; Nicaud V; Aubry ML; Fiessinger JN; Aiach M; Emmerich J
Thromb Haemost; 1999 Apr; 81(4):506-10. PubMed ID: 10235429
[TBL] [Abstract][Full Text] [Related]
3. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis--evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation.
Schobess R; Junker R; Auberger K; Münchow N; Burdach S; Nowak-Göttl U
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S105-8. PubMed ID: 10650846
[TBL] [Abstract][Full Text] [Related]
4. Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V Leiden.
Medina P; Navarro S; Estellés A; Vayá A; Bertina RM; España F
Thromb Haemost; 2005 Aug; 94(2):389-94. PubMed ID: 16113830
[TBL] [Abstract][Full Text] [Related]
5. The prothrombin gene G20210A variant in an unselected thromboembolic population. A Belgian prospective clinical study.
Hainaut P; Gala JL; Lesage V; Lavenne E; Azerad MA; Zech F; Heusterspreute M; Philippe M; Moriau M
Acta Clin Belg; 1998 Oct; 53(5):344-8. PubMed ID: 9861761
[TBL] [Abstract][Full Text] [Related]
6. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
[TBL] [Abstract][Full Text] [Related]
7. Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutation.
Rintelen C; Pabinger I; Bettelheim P; Lechner K; Kyrle PA; Knöbl P; Schneider B; Mannhalter C
Eur J Haematol; 2001 Sep; 67(3):165-9. PubMed ID: 11737249
[TBL] [Abstract][Full Text] [Related]
8. Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis.
Martinelli I; Taioli E; Bucciarelli P; Akhavan S; Mannucci PM
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):700-3. PubMed ID: 10073976
[TBL] [Abstract][Full Text] [Related]
9. Clinical and laboratory expression of associated thrombophilic conditions (homozygous/heterozygous factor V Leiden mutation and heterozygous prothrombin variant 20210A) in an Italian family.
Simioni P; Tormene D; Luni S; Caldato M; Girolami A
Blood Coagul Fibrinolysis; 2000 Jun; 11(4):379-84. PubMed ID: 10847426
[TBL] [Abstract][Full Text] [Related]
10. Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism.
Margaglione M; D'Andrea G; Colaizzo D; Cappucci G; del Popolo A; Brancaccio V; Ciampa A; Grandone E; Di Minno G
Thromb Haemost; 1999 Dec; 82(6):1583-7. PubMed ID: 10613638
[TBL] [Abstract][Full Text] [Related]
11. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation.
Lindmarker P; Schulman S; Sten-Linder M; Wiman B; Egberg N; Johnsson H
Thromb Haemost; 1999 May; 81(5):684-9. PubMed ID: 10365737
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors.
Nowak-Göttl U; Wermes C; Junker R; Koch HG; Schobess R; Fleischhack G; Schwabe D; Ehrenforth S
Blood; 1999 Mar; 93(5):1595-9. PubMed ID: 10029588
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis.
Gemmati D; Serino ML; Moratelli S; Tognazzo S; Ongaro A; Scapoli GL
Haemostasis; 2001; 31(2):99-105. PubMed ID: 11684865
[TBL] [Abstract][Full Text] [Related]
14. Additional genetic risk factors for venous thromboembolism in carriers of the factor V Leiden mutation.
Tosetto A; Rodeghiero F; Martinelli I; De Stefano V; Missiaglia E; Chiusolo P; Mannucci PM
Br J Haematol; 1998 Dec; 103(3):871-6. PubMed ID: 9858248
[TBL] [Abstract][Full Text] [Related]
15. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
Marchiori A; Mosena L; Prins MH; Prandoni P
Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of the FV:Q506 mutation in unselected oncology patients.
Otterson GA; Monahan BP; Harold N; Steinberg SM; Frame JN; Kaye FJ
Am J Med; 1996 Oct; 101(4):406-12. PubMed ID: 8873512
[TBL] [Abstract][Full Text] [Related]
17. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.
Bank I; Libourel EJ; Middeldorp S; Van Pampus EC; Koopman MM; Hamulyák K; Prins MH; Van Der Meer J; Büller HR
Arch Intern Med; 2004 Sep; 164(17):1932-7. PubMed ID: 15451770
[TBL] [Abstract][Full Text] [Related]
18. The first homozygous family for prothrombin G20210A polymorphism reported in Latin America.
Roman-Gonzalez A; Cardona H; Cardona-Maya W; Alvarez L; Castaneda S; Martinez J; Torres JD; Tobon L; Bedoya G; Cadavid A
Clin Appl Thromb Hemost; 2009 Feb; 15(1):113-6. PubMed ID: 18829602
[TBL] [Abstract][Full Text] [Related]
19. Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings.
Colaizzo D; Amitrano L; Iannaccone L; Vergura P; Cappucci F; Grandone E; Guardascione MA; Margaglione M
J Med Genet; 2007 Jun; 44(6):412-6. PubMed ID: 17307838
[TBL] [Abstract][Full Text] [Related]
20. Prothrombin A19911G polymorphism and the risk of venous thromboembolism.
Martinelli I; Battaglioli T; Tosetto A; Legnani C; Sottile L; Ghiotto R; Mannucci PM
J Thromb Haemost; 2006 Dec; 4(12):2582-6. PubMed ID: 16981886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
